Skip to main content
Clinical Trials/NL-OMON34112
NL-OMON34112
Not yet recruiting
Phase 4

A Comparison of Drug Eluting and Bare Metal Stents with Bivalirudin during PCI or Bivalirudin for 4 hours in Acute Coronary Syndromes. The Eindhoven Reperfusion Study - The DEBATER 2 Trial

Catharina-ziekenhuis0 sites1,800 target enrollmentTBD

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Acute myocardial infarction
Sponsor
Catharina-ziekenhuis
Enrollment
1800
Status
Not yet recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • STEMI \<12 hours (or STE equivalent), or NSTEMI \<48 hours
  • No contraindication for PCI, abciximab, bivalirudin or clopidogrel
  • Informed consent from the patient

Exclusion Criteria

  • Contraindication for PCI, GPI, bivalirudin or clopidogrel
  • Thrombolytic therapy within the last 24 hours
  • Therapy with GPI within the last 24 hours
  • Anticoagulantion therapy
  • No Informed Consent

Outcomes

Primary Outcomes

Not specified

Similar Trials